1. S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up.
- Author
-
Lang BM, Balermpas P, Bauer A, Blum A, Brölsch GF, Dirschka T, Follmann M, Frank J, Frerich B, Fritz K, Hauschild A, Heindl LM, Howaldt HP, Ihrler S, Kakkassery V, Klumpp B, Krause-Bergmann A, Löser C, Meissner M, Sachse MM, Schlaak M, Schön MP, Tischendorf L, Tronnier M, Vordermark D, Welzel J, Weichenthal M, Wiegand S, Kaufmann R, and Grabbe S
- Subjects
- Aged, Aged, 80 and over, Carcinoma, Basal Cell epidemiology, Carcinoma, Basal Cell prevention & control, Carcinoma, Basal Cell therapy, Disease Management, Follow-Up Studies, Germany epidemiology, Humans, Incidence, Middle Aged, Neoplasm Recurrence, Local epidemiology, Neoplasm Recurrence, Local pathology, Neoplasm Recurrence, Local prevention & control, Practice Guidelines as Topic, Risk Assessment, Skin Neoplasms epidemiology, Skin Neoplasms therapy, Carcinoma, Basal Cell pathology, Managed Care Programs standards, Quality of Health Care standards, Skin Neoplasms pathology
- Abstract
Basal cell carcinoma (BCC) is the most common malignant tumor among fair-skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow-up of patients with basal cell carcinoma., (© 2019 The Authors | Journal compilation © Blackwell Verlag GmbH, Berlin.)
- Published
- 2019
- Full Text
- View/download PDF